Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction

The hypoxia inducible factor (HIF) pathway has been considered to be an attractive anti-cancer target. One strategy to inhibit HIF activity is through the disruption of the HIF-1α–p300 protein-protein interaction. We report herein the identification of an osmium(II) complex as the first metal-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chao, Wang, Wanhe, Li, Guo-Dong, Zhong, Hai-Jing, Dong, Zhen-Zhen, Wong, Chun-Yuen, Kwong, Daniel W. J., Ma, Dik-Lung, Leung, Chung-Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320473/
https://www.ncbi.nlm.nih.gov/pubmed/28225008
http://dx.doi.org/10.1038/srep42860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320473/
https://www.ncbi.nlm.nih.gov/pubmed/28225008
http://dx.doi.org/10.1038/srep42860

Ejemplares similares